ORIC · Oric Pharmaceuticals, Inc.

Track ORIC — free

$13.87 +0.15 (+1.09%) At close · Aug 14

Market Cap

$1.44B

103.65M

Up next

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Aug 3, 2026

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Strong Buy Momentum Very Strong Sentiment Bullish Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 14.3 · calm Equity put/call 0.52

Technical

price trend

Strong Buy

50 / 200-day cross Golden cross

Price vs 200-day avg +31%

above

Price vs 50-day avg +31%

above

RSI (14) 68

neutral

MACD trend Positive

52-week position 92%

near high

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Strong

1-month return +29%

trailing

6-month return +18%

trailing

YTD return +70%

this year

Relative strength +5%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) Golden cross

50d $11 › 200d $11 — 50d above 200d

Institutional flow Distributing

-1% holders QoQ · +32 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

21.04% of float · ▼ -1.1% MoM · 13.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

180 holders — near 3-yr high, broad support

Squeeze score 76

high risk · 0–100

Fundamentals

Strong

EPS growth +20%

Y/Y

Free cash flow $-111.7M

Balance sheet $35.2M

net cash

Quant / Vol

risk profile

Very High

Volatility 86%

annualized · 1-yr

Max drawdown −48%

past year

ATR 5.8%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Buy

0 · 2 · 5

50 / 200-day cross

Golden cross Bullish

Price vs 200-day avg

+31% Bullish

Price vs 50-day avg

+31% Bullish

RSI (14)

68 Neutral

MACD trend

Positive Bullish

52-week position

92% Bullish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) Golden cross

50d $11 › 200d $11 — 50d above 200d

Institutional flow Distributing

-1% holders QoQ · +32 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

21.04% of float · ▼ -1.1% MoM · 13.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

180 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $7 Now $14 · 92% Range high $14

vs 200-day avg +31% vs 50-day avg +31% 50-day above 200-day golden cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Cash, cash equivalents and investments	$387.6M	Q2 2026	—
Proforma cash and investments	$412.3M	as of December 31, 2025	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
ORIC Oric Pharmaceuticals, Inc. this stock	$1.44B	+69.6%	—	—	21.0%
ONC BeOne Medicines Ltd.	$513.62B	+14.4%	+22179.2%	789.7	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$128.19B	+11.6%	+46.2%	29.5	1.6%
REGN Regeneron Pharmaceuticals, Inc.	$82.72B	+4.1%	+20.8%	19.9	3.3%
ARGX Argenx SE	$52.94B	+1.2%	—	—	2.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

180

% held: 119.6%
Net QoQ: +4.5M sh
Top holder: Nextech Invest, Ltd.

Held Float

View

Held by Funds

Fund positions

205

View

Short & Settlement

Short Interest Falling

Shares short

21.8M

Days to cover: 13.6d
Change: -248.2K sh

View

Short Volume

Short vol %

39%

As of: Aug 14, 2026

Short Total

View

Fails to Deliver

FTD shares

32.7K

Value: $354.9K
As of: Jul 13, 2026

View

Off-Exchange

Off-exchange %

36.8%

Week of: Jul 6, 2026

Off-exch Lit

View

Financials

Net income (FY)

$-129.5M

EPS diluted: $-1.47

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 3, 2026
This year: 13

View

Proposed Sales

Value

$702.0K

Shares: 52.0K
Filed: Feb 24, 2026

View

Exempt Offerings

Offering

$125.0M

Filed: Jun 6, 2025

View

Earnings & Events

Earnings Calls

Last call

Jun 9, 2026

View

Performance

	5D	20D	120D	MTD	YTD
ORIC	+2.7%	+29.3%	+18.5%	+25.3%	+69.6%
SPY	+0.4%	+4.5%	+13.8%	+3.9%	+13.9%
vs SPY	+2.3%	+24.8%	+4.7%	+21.4%	+55.7%

Key facts CIK 1796280 CUSIP 68622P109 13F (30d) 176 filings 175 filers Visit website Investor relations

ORIC · Oric Pharmaceuticals, Inc.

Price & Indicators

Up next

Equibles Rating

Technicals

Key metrics

Versus peers

At a glance

Performance